08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
This year there were a number of significant legislative changes to the Virginia Stock Corporation A...
Read More >
MTA Royalty Corp. v. Compania Minera Pangea, S.A. DE C.V., C.A. No. N19C-11-228 AML CCLD (Del. Supe...
Read More >
The Situation: The Australian Government has temporarily reduced the monetary thresholds under the F...
Read More >
Have you ever wondered when Massachusetts’ 6-year statute of repose for defective design, planning ...
Read More >
Now that the 2018 EEO-1 Component 1 filing deadline has passed, employers have been anxiously awaiti...
Read More >
The Competition Tribunal has released extensive reasons for dismissing the abuse of dominance claim ...
Read More >